Frailty is a determinant of suboptimal chemotherapy in women with advanced ovarian cancer

Deepa Maheswari Narasimhulu, Michaela E. McGree, Amy L. Weaver, Aminah Jatoi, Nathan K. LeBrasseur, Gretchen Glaser, Carrie Langstraat, Matthew S. Block, Amanika Kumar